Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mereo BioPharma (MREO) Non Operating Income (2023)

Mereo BioPharma (MREO) has disclosed Non Operating Income for 1 consecutive years, with -$4000.0 as the latest value for Q4 2023.

  • On a quarterly basis, Non Operating Income changed N/A to -$4000.0 in Q4 2023 year-over-year; TTM through Sep 2024 was -$4000.0, a N/A change, with the full-year FY2023 number at -$10000.0, down 100.92% from a year prior.
  • Non Operating Income was -$4000.0 for Q4 2023 at Mereo BioPharma, up from -$6000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of -$4000.0 in Q4 2023 to a low of -$6000.0 in Q1 2023.